Katherine A Barraclough

Summary

Country: Australia

Publications

  1. pmc BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
    J Transplant 2011:750836. 2011
  2. doi A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients
    Katherine A Barraclough
    Department of Nephrology, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 17:294-9. 2012
  3. pmc The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial
    William G Petchey
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    BMC Nephrol 10:41. 2009
  4. doi Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Level 2, ARTS Building, Ipswich Road, Woolloongabba, Brisbane 4102, QLD, Australia
    Eur J Clin Pharmacol 67:1243-52. 2011
  5. pmc Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
    Br J Clin Pharmacol 71:207-23. 2011
  6. doi Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Ther Drug Monit 32:723-33. 2010
  7. doi Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation
    Katherine A Barraclough
    Department of Renal Medicine, University of Queensland at the Princess Alexandra Hospital, Queensland, Australia
    Nephrology (Carlton) 15:522-32. 2010
  8. doi Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials
    Katherine A Barraclough
    Department of Renal Medicine, University of Queensland at the Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia
    Transplantation 90:44-51. 2010
  9. doi Pharmacogenetic influences on mycophenolate therapy
    Katherine A Barraclough
    Department of Nephrology, Level 2, ARTS Building, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, QLD 4102, Australia
    Pharmacogenomics 11:369-90. 2010
  10. doi Hepatitis B virus infection in hemodialysis populations: progress toward prevention
    Katherine A Barraclough
    Department of Nephrology, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia
    Kidney Int 77:177-80. 2010

Detail Information

Publications23

  1. pmc BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
    J Transplant 2011:750836. 2011
    ..Evidence supporting the various immunosuppression reduction strategies utilised in the management of BK virus will also be briefly discussed...
  2. doi A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients
    Katherine A Barraclough
    Department of Nephrology, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Nephrology (Carlton) 17:294-9. 2012
    ..The aim of this study was to develop a limited sampling strategy (LSS) for the simultaneous estimation of exposure to tacrolimus, mycophenolic acid and unbound prednisolone in adult kidney transplant recipients...
  3. pmc The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial
    William G Petchey
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    BMC Nephrol 10:41. 2009
    ..Secondary hypotheses will test whether this is associated with decreased inflammation and bone/adipocyte-endocrine dysregulation...
  4. doi Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Level 2, ARTS Building, Ipswich Road, Woolloongabba, Brisbane 4102, QLD, Australia
    Eur J Clin Pharmacol 67:1243-52. 2011
    ....
  5. pmc Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
    Br J Clin Pharmacol 71:207-23. 2011
    ..To examine the predictive performance of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients...
  6. doi Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Ther Drug Monit 32:723-33. 2010
    ..High variability in performance of LSSs highlights the importance of validating any LSS before applying it to an alternative population. Attention to comedication use is of particular relevance when choosing a LSS...
  7. doi Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation
    Katherine A Barraclough
    Department of Renal Medicine, University of Queensland at the Princess Alexandra Hospital, Queensland, Australia
    Nephrology (Carlton) 15:522-32. 2010
    ..The purpose of this review is to provide the clinician with an overview of the methodology and use of immune function monitoring in the field of kidney transplantation...
  8. doi Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials
    Katherine A Barraclough
    Department of Renal Medicine, University of Queensland at the Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia
    Transplantation 90:44-51. 2010
    ..Results were conflicting. This study aimed to compare the ability of these methodologies to predict AUC(0-12) in an independent cohort of kidney transplant recipients...
  9. doi Pharmacogenetic influences on mycophenolate therapy
    Katherine A Barraclough
    Department of Nephrology, Level 2, ARTS Building, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, QLD 4102, Australia
    Pharmacogenomics 11:369-90. 2010
    ..This article provides an extensive overview of the known effects of these SNPs on the pharmacokinetics and pharmacodynamics of MPA...
  10. doi Hepatitis B virus infection in hemodialysis populations: progress toward prevention
    Katherine A Barraclough
    Department of Nephrology, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia
    Kidney Int 77:177-80. 2010
    ..However, its ability to improve overall seroconversion response remains unproven...
  11. doi Prevention of access-related infection in dialysis
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Expert Rev Anti Infect Ther 7:1185-200. 2009
    ....
  12. pmc Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    BMC Nephrol 10:20. 2009
    ....
  13. doi Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Am J Kidney Dis 54:95-103. 2009
    ..Primary hepatitis B virus (HBV) vaccination through the intramuscular (IM) route is less efficacious in dialysis patients than in the general population. Previous studies suggest improved seroconversion with intradermal (ID) vaccination...
  14. doi Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, QLD, Australia
    Transpl Int 25:1182-93. 2012
    ..1, 284.4), P = 0.001]. This study highlights the importance of achieving early target exposure and suggests a potential role for individualized initial dosing or early therapeutic monitoring of all three immunosuppressive agents...
  15. doi A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on sCD30 levels in adult kidney transplant recipients
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Ther Drug Monit 35:240-5. 2013
    ..However, there has been minimal study of the influence of individual immunosuppressive drugs on sCD30 levels...
  16. doi A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Nephrol Dial Transplant 27:4146-53. 2012
    ..The aim of this multi-centre randomized controlled trial was to determine the ability of HIP administration to augment iron stores in darbepoetin (DPO)-treated patients compared with conventional oral iron supplementation...
  17. doi NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, Australia
    Transplantation 94:1025-32. 2012
    ..Pregnane X, encoded by the gene NR112, is a nuclear receptor whose primary role is to promote the detoxification and clearance of drugs and other foreign compounds from the body...
  18. doi Once- versus twice-daily tacrolimus: are the formulations truly equivalent?
    Katherine A Barraclough
    Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, QLD, Australia
    Drugs 71:1561-77. 2011
    ..This article reviews the pharmacokinetics, efficacy, adverse effects and utility of Advagraf® in relation to its equivalence to Prograf®, and areas that require additional research are identified...
  19. doi Comparison of the influence of cyclosporine and tacrolimus on the pharmacokinetics of prednisolone in adult male kidney transplant recipients
    Troels K Bergmann
    School of Pharmacy, University of Queensland, Brisbane, Australia
    Clin Drug Investig 34:183-8. 2014
    ..The objective of this study was to determine whether cyclosporine impacts on prednisolone exposure as compared with tacrolimus...
  20. doi Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation
    Troels K Bergmann
    University of Queensland School of Pharmacy, Pharmacy Australia Centre of Excellence, 20 Cornwall St, Woolloongabba, Brisbane, QLD, 4102, Australia
    Clin Pharmacokinet 51:711-41. 2012
    ....
  21. doi Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose
    Troels K Bergmann
    School of Pharmacy, University of Queensland, Brisbane, Australia Department of Pharmacology, Aarhus University, Aarhus, Denmark and Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, Australia
    Ther Drug Monit 36:62-70. 2014
    ....
  22. doi A practical limited sampling strategy to predict free prednisolone exposure and glycemia in kidney transplant recipients
    Christopher J Yates
    Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, Queensland, Australia Department of Chemical Pathology, Pathology Queensland, Royal Brisbane and Women s Hospital, Brisbane, Queensland, Australia Departments of Chemical Pathology, and Nephrology, Royal Melbourne Hospital, Parkville, Victoria, Australia and Department of Medicine, NorthWest Academic Centre, University of Melbourne, St Albans, Victoria, Australia
    Ther Drug Monit 36:18-23. 2014
    ....
  23. ncbi Renal graft rejection after allogeneic peripheral-blood stem cell transplantation
    Katherine A Barraclough
    Department of Renal Medicine, Bone Marrow Transplant Program, Alfred Hospital, Melbourne, Australia
    Am J Kidney Dis 48:822-6. 2006
    ..We speculate that the engrafting third-party hematopoiesis produced acute renal allograft rejection with secondary microangiopathic hemolysis through a graft-versus-graft mechanism...